Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 52
Filter
1.
Cas Lek Cesk ; 147(9): 471-7, 2008.
Article in Czech | MEDLINE | ID: mdl-18988489

ABSTRACT

Recently, Gilead Sciences (Foster City, CA, USA) presented a potential cytostatic drug GS-9219. It is a novel lipophilic prodrug of cyprPMEDAP, in vivo releasing the active compound PMEG in a two-step process. GS-9219 has shown a substantial therapeutic potential in treatment of spontaneous non-Hodgkin's lymphoma in dogs and its utilization in the human medicine is prospective. Hence, cyprPMEDAP represents a key intermediate in the intracellular activation of GS-9219. Both acyclic nucleoside phosphonates PMEG and cyprPMEDAP, serving as the basis for development of GS-9219, were discovered and their mechanism of action was investigated in detail at the Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic. The biological studies using the rat lymphoma were carried out at the First Faculty of Medicine, Charles University.


Subject(s)
Antineoplastic Agents , Nucleosides , Organophosphonates , Adenine/analogs & derivatives , Adenine/pharmacology , Adenine/therapeutic use , Alanine/analogs & derivatives , Alanine/pharmacology , Alanine/therapeutic use , Animals , Antineoplastic Agents/pharmacology , Antineoplastic Agents/therapeutic use , Cell Line, Tumor/drug effects , Guanine/analogs & derivatives , Guanine/pharmacology , Guanine/therapeutic use , Humans , Lymphoma, Non-Hodgkin/drug therapy , Nucleosides/pharmacology , Nucleosides/therapeutic use , Organophosphonates/pharmacology , Organophosphonates/therapeutic use , Organophosphorus Compounds/pharmacology , Organophosphorus Compounds/therapeutic use , Purines/pharmacology , Purines/therapeutic use
2.
Folia Biol (Praha) ; 53(3): 79-84, 2007.
Article in English | MEDLINE | ID: mdl-17579998

ABSTRACT

The role of MRP4 and MRP5 transporters in the acyclic nucleoside phosphonate PMEDAP efflux was studied in vitro (CCRF-CEM cells) and in vivo (spontaneous transplantable T-cell lymphoma of SD/Cub inbred rats). The increased resistance against the cytostatic agent PMEDAP during longterm treatment was found to be associated with overexpression of MRP4 and MRP5 genes. The course of both gene activation differs significantly. While the MRP5 function is important in the onset of PMEDAP resistance, the intensity of the relative MRP4 gene expression increases rather continuously. Our data indicate cooperative acting of both MRP4 and MRP5 genes during the PMEDAP resistance development.


Subject(s)
Adenine/analogs & derivatives , Antineoplastic Agents/therapeutic use , Drug Resistance, Neoplasm , Lymphoma/drug therapy , Adenine/therapeutic use , Animals , Cell Line, Tumor , Gene Expression Regulation, Neoplastic , Humans , Lymphoma/genetics , Male , Multidrug Resistance-Associated Proteins/genetics , Multidrug Resistance-Associated Proteins/metabolism , Neoplasm Transplantation , Organ Size , Rats , Rats, Sprague-Dawley , Transcriptional Activation
3.
Cas Lek Cesk ; 145(9): 688-94, 2006.
Article in Czech | MEDLINE | ID: mdl-17091723

ABSTRACT

Contemporary views on the mechanisms of aging and aging variations--progeria and longevity are presented. Replicative aging, the roles of glycation and free radicals on the genetical determination of progeria and longevity are discussed.


Subject(s)
Aging/physiology , Antioxidants/metabolism , Apoptosis , Calcium/metabolism , Cell Cycle , Cell Division , Free Radicals/metabolism , Glucose/metabolism , Humans , Lipid Peroxidation , Longevity/genetics , Mutation , Progeria/physiopathology , Telomere/genetics
4.
Leukemia ; 18(3): 434-41, 2004 Mar.
Article in English | MEDLINE | ID: mdl-14724653

ABSTRACT

L-Asparaginase is a standard component in chemotherapy of childhood acute lymphoblastic leukaemia (ALL). Leukaemic cells carrying TEL/AML1 fusion gene are more sensitive to treatment with L-asparaginase compared to other subtypes of ALL. We demonstrate in vitro the prolonged growth suppression of TEL/AML1[+] cells compared to TEL/AML1[-] leukaemic cells after L-asparaginase treatment simulating treatment protocol. Cell cycle analysis revealed TEL/AML1[+] cells to accumulate in G1/G0 phase (81-98%) compared to TEL/AML1[-] cells (47-60%). Quantitative analysis of asparagine synthetase (AsnS) expression showed the ability of TEL/AML1[+] cells to increase AsnS mRNA levels after L-asparaginase treatment to the same extent as TEL/AML1[-] leukaemic and nonleukaemic lymphoid cells. We hypothesise that TEL/AML1[+] cells are unable to progress into the S phase of cell cycle under nutrition stress caused by L-asparaginase, despite the ability of AsnS upregulation. Significantly higher expression of AsnS was found in untreated leukaemic cells from children with TEL/AML1[+] ALL (n=20) in comparison with the group of age-matched children with ALL bearing no known fusion gene (n=25; P=0.0043). Interestingly, none of the TEL/AML1[+] patients with high AsnS level relapsed, whereas 10/15 patients with AsnS below median relapsed (P=0.00028). Therefore, high AsnS levels in TEL/AML1[+] patients correlate with better prognosis, possibly reflecting the stretched metabolic demand of the lymphoblast.


Subject(s)
Asparaginase/therapeutic use , Aspartate-Ammonia Ligase/metabolism , Cell Cycle , Oncogene Proteins, Fusion/metabolism , Precursor Cell Lymphoblastic Leukemia-Lymphoma/enzymology , Bone Marrow , Child , Child, Preschool , Core Binding Factor Alpha 2 Subunit , Humans , Neoplasm Recurrence, Local/metabolism , Neoplasm Recurrence, Local/pathology , Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics , Precursor Cell Lymphoblastic Leukemia-Lymphoma/pathology , RNA, Messenger/genetics , RNA, Neoplasm/genetics , Reverse Transcriptase Polymerase Chain Reaction , Tumor Cells, Cultured , Up-Regulation
5.
Folia Biol (Praha) ; 48(6): 213-26, 2002.
Article in English | MEDLINE | ID: mdl-12512796

ABSTRACT

More than a decade of experimental work in an inbred subline of Sprague-Dawley rats having high incidence of spontaneous T-cell lymphoma/leukaemia is reviewed. Longitudinal follow-up of biological characteristics (growth, survival, haematology) of both multiple cases of primary disease and s.c. passaged lymphomas as well as comparative immunophenotypic and karyotypic studies are concluded. In these T-cell lymphomas (mostly CD4 positive), arising on the same genetic background of the inbred SD strain, the aberrations involving chromosome 11 have been recognized as a typical non-random cytogenetic marker. This unique rat model of lymphoblastic lymphomas/leukaemias, relevant to human pathology, seems to be very suitable for testing different anticancer therapeutic strategies, as it is documented by results of a number of various protocols conducted in our laboratory.


Subject(s)
Disease Models, Animal , Leukemia-Lymphoma, Adult T-Cell , Precursor Cell Lymphoblastic Leukemia-Lymphoma , Aging/physiology , Animals , Antineoplastic Agents/therapeutic use , Humans , Immunophenotyping , Leukemia-Lymphoma, Adult T-Cell/drug therapy , Leukemia-Lymphoma, Adult T-Cell/genetics , Leukemia-Lymphoma, Adult T-Cell/pathology , Leukemia-Lymphoma, Adult T-Cell/physiopathology , Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics , Precursor Cell Lymphoblastic Leukemia-Lymphoma/pathology , Precursor Cell Lymphoblastic Leukemia-Lymphoma/physiopathology , Rats , Rats, Sprague-Dawley , Survival Rate
6.
J Med Chem ; 44(25): 4462-7, 2001 Dec 06.
Article in English | MEDLINE | ID: mdl-11728191

ABSTRACT

O-Phosphonatomethylcholine, an isopolar phosphocholine analogue with a phosphonomethyl ether group replacing a phosphomonoester residue, was prepared by reaction of diisopropyl 2-chloroethoxymethylphosphonate with dimethylamine followed by quaternization of the thus-obtained diisopropyl 2-dimethylaminoethoxymethylphosphonate with iodomethane; the ester groups in the quaternary intermediate were cleaved with bromotrimethylsilane. Replacement of dimethylamine in the reaction sequence by morpholine and/or pyrrolidine gave the N-methylmorpholinium or N-methylpyrrolidinium analogues of O-phosphonatomethylcholine. Reaction of O-phosphonomethylcholine monotetrabutylammonium salt with 1-bromoalkanes in acetonitrile afforded a series of the corresponding monoalkyl (C10-C16) esters. None of these compounds except for the hexadecyl ester exhibited any appreciable cytostatic activity against DU-145, H460, HT-29, or MES-SA cell lines in vitro (evaluated by 3H-Thd incorporation assay). The hexadecyl ester exhibited modest in vitro cytotoxic activity comparable to that of the anticancer drug miltefosine (hexadecyl O-phosphocholine). In vivo evaluation of hexadecyl O-phosphonomethylcholine [transplanted SD lymphoma in inbred SD/cub rats, 10 mg kg(-1) day(-1) intratumoral injection for 10 days] resulted in a 40% decrease in lymphoma mass.


Subject(s)
Antineoplastic Agents/chemical synthesis , Choline/chemical synthesis , Organophosphonates/chemical synthesis , Phosphorylcholine/analogs & derivatives , Phosphorylcholine/chemical synthesis , Animals , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Choline/analogs & derivatives , Choline/chemistry , Choline/pharmacology , Drug Screening Assays, Antitumor , Humans , Male , Organophosphonates/chemistry , Organophosphonates/pharmacology , Phosphorylcholine/chemistry , Phosphorylcholine/pharmacology , Rats , Structure-Activity Relationship , Transplantation, Heterologous , Tumor Cells, Cultured
7.
Anticancer Res ; 21(4A): 2725-31, 2001.
Article in English | MEDLINE | ID: mdl-11724347

ABSTRACT

Antitumour efficiency of combined therapy with N-9-[2-(phosphonomethoxy)ethyl]-2,6-diaminopurine (PMEDAP) and docetaxel (DTX) was studied in an in vivo model of s.c. transplanted Sprague-Dawley (SD/Cub) rat T-cell lymphoma (phenotype SD10/96). The effect of the combined treatment of DTX with PMEDAP was significantly higher than that of DTX or PMEDAP alone. The s.c. administration of DXT into the vicinity of growing lymphoma together with i.p. administration of PMEDAP was found to be the most efficient combination. In this case, two out of four rats did not develop any lymphoma and remained alive. An irregular expression of Bcl2 protein was found in untreated and treated lymphomas, while the expression of protein p53 as well as MDM2 was not observed. All three types of the above-mentioned treatments (PMEDAP, DXT, DXT+PMEDAP) increased significantly the number of p21-positive cells, compared with untreated tumours.


Subject(s)
Adenine/analogs & derivatives , Antineoplastic Combined Chemotherapy Protocols/pharmacology , Lymphoma, T-Cell/drug therapy , Paclitaxel/analogs & derivatives , Taxoids , Adenine/administration & dosage , Animals , Antineoplastic Agents, Phytogenic/administration & dosage , Antineoplastic Agents, Phytogenic/blood , Antineoplastic Agents, Phytogenic/pharmacology , Disease Models, Animal , Docetaxel , Drug Synergism , Female , Injections, Intraperitoneal , Injections, Subcutaneous , Male , Neoplasm Transplantation , Paclitaxel/administration & dosage , Paclitaxel/blood , Paclitaxel/pharmacology , Rats , Rats, Sprague-Dawley
8.
Anticancer Res ; 21(3B): 2057-64, 2001.
Article in English | MEDLINE | ID: mdl-11497298

ABSTRACT

The antitumour activity of four N6-substituted PMEDAP derivatives, Me2NEt-PMEDAP, allyl-PMEDAP, Me2-PMEDAP and cypr-PMEDAP, selected on the basis of their in vitro cytostatic activity, was studied in an in vivo model of haematological malignancy of inbred Sprague-Dawley rats. These compounds are believed to serve as the prodrugs of another (phosphonomethoxy)ethyl derivative, PMEG (9-[2-phosphonomethoxy) ethyl] guanine. We compared their toxicity and ability to inhibit tumour development in two different dosage regimes with those of their parent compound PMEDAP, as well with PMEG. The study confirmed the anticancer efficacy of the parental compound PMEDAP. Unlike PMEDAP, its N6-mono- and disubstituted congeners Me2NEt-PMEDAP, allyl-PMEDAP and Me2-PMEDAP were less potent or exhibited the same antineoplastic effect as PMEDAP. cypr-PMEDAP significantly decreased the survival of lymphoma-bearing rats due to high toxicity, which was approximately the same as that of PMEG. Therefore, these acyclic nucleoside phosphonates substituted at the 6-position of 2,6-diaminopurine ring do not seem to be promising drugs for the treatment of haematological malignancies.


Subject(s)
Adenine/analogs & derivatives , Adenine/pharmacology , Antineoplastic Agents/pharmacology , Prodrugs/pharmacology , Animals , Blood Cell Count , Bone Marrow Cells/metabolism , Dose-Response Relationship, Drug , Female , Karyotyping , Lymphoma/drug therapy , Male , Mitosis , Neoplasm Transplantation , Organophosphonates/pharmacology , Rats , Rats, Sprague-Dawley , Time Factors
9.
Immunopharmacol Immunotoxicol ; 23(1): 67-74, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11322650

ABSTRACT

The modulatory effect of FK 506 and cyclosporin A (CsA) on the expression of inducible nitric oxide synthase (iNOS) in macrophages and mechanisms of their action were analysed. Isolated rat peritoneal macrophages were cultured for 12 or 24 h with or without lipopolysaccharide (LPS) (5 microg/ml) and in the absence or presence of FK 506 or CsA (0.1 and 1 microg/ml). Total RNA from macrophages was isolated and the expression of the gene for iNOS was assessed by using RT-PCR. The concentration of NO2- in culture supernatants was taken as a measure of nitric oxide (NO) production. FK 506 (0.1 and 1 microg/ml) reduced the LPS-induced increase of NO2- levels by 68% and 81%, respectively. CsA (0.1 and 1 microg/ml) decreased levels of nitrites by 39% and 69%, respectively. The results obtained suggest that both immunosuppressive drugs exhibit dose-dependent inhibitory effect on NO production and that FK 506 is more potent agent than CsA, in this respect. FK 506 exhibits its inhibitory effect on a phosphatase at the transcriptional level in macrophages. iNOS expression down-regulation by CsA is occurred post-transcriptionally.


Subject(s)
Cyclosporine/pharmacology , Immunosuppressive Agents/pharmacology , Lipopolysaccharides/pharmacology , Macrophages, Peritoneal/drug effects , Nitric Oxide Synthase/metabolism , Tacrolimus/pharmacology , Animals , Cells, Cultured , Dose-Response Relationship, Drug , Down-Regulation , Electrophoresis, Agar Gel , Gene Expression Regulation, Enzymologic , Macrophages, Peritoneal/enzymology , Male , Nitric Oxide/metabolism , Nitric Oxide Synthase/genetics , Nitric Oxide Synthase Type II , RNA, Messenger/metabolism , Rats , Rats, Wistar , Reverse Transcriptase Polymerase Chain Reaction
10.
Anticancer Res ; 20(2A): 1041-7, 2000.
Article in English | MEDLINE | ID: mdl-10810395

ABSTRACT

Antitumor effect of N-9-[2-(phosphonomethoxy) ethyl]-2,6-diaminopurine (PMEDAP) was studied in an in vivo model of s.c. transplanted Sprague-Dawley (SD/cub) rat T-cell lymphomas. Three individual SD/cub neoplasias (SD10/96, SD14/97, SD1/90) of different phenotypes were used. During the treatment, survival of the rats, increase of lymphoma mass, and DNA fragmentation detected by APO/BRDU kit, as well as Bcl2 and p53 protein expression, were followed. The study gives evidence of the positive therapeutic effect of PMEDAP in two of the three tested lymphomas, SD10/96 and SD14/97. Slowly growing SD1/90 lymphoma differs from the others in a uniform karyotype with trisomy of chromosome 11, CD4- immunophenotype, heterogeneous cellular morphology and constitutive expression of p53 protein found in some neoplastic cells. Thus, the diverse anticancer efficacy of PMEDAP treatment among SD/cub lymphomas could be associated with the different phenotypes of individual neoplasias.


Subject(s)
Adenine/analogs & derivatives , Antineoplastic Agents/therapeutic use , Apoptosis/drug effects , Lymphoma, T-Cell/drug therapy , Lymphoma, T-Cell/pathology , Adenine/therapeutic use , Animals , Chromosome Mapping , Immunohistochemistry , In Situ Nick-End Labeling , Karyotyping , Lymphoma, T-Cell/genetics , Proto-Oncogene Proteins c-bcl-2/analysis , Rats , Rats, Sprague-Dawley , Trisomy , Tumor Suppressor Protein p53/analysis
11.
Physiol Res ; 49(6): 725-8, 2000.
Article in English | MEDLINE | ID: mdl-11252540

ABSTRACT

We analyzed the effect of FK 506 on the production of nitric oxide by macrophages. Isolated rat peritoneal macrophages were cultured for 24 h with or without lipopolysaccharide (LPS) (5 microg/ml) and in the absence or presence of FK 506 (0.1 and 1 microg/ml). The concentration of NO2- in culture supernatants was taken as a measure of nitric oxide production. FK 506 (0.1 and 1 microg/ml) reduced the LPS-induced increase of NO2- levels by 68% and 81%, respectively. The impact of cyclosporin A (CsA) was studied in order to compare their effects. CsA (0.1 and 1 microg/ml) decreased the levels of nitrites by 39% and 69%, respectively. The results obtained suggest that both immunosuppressive drugs exhibit a dose-dependent inhibitory effect on nitric oxide production and that FK 506 is a more potent agent than CsA in this respect.


Subject(s)
Cyclosporine/pharmacology , Immunosuppressive Agents/pharmacology , Lipopolysaccharides/pharmacology , Macrophages, Peritoneal/drug effects , Nitric Oxide/biosynthesis , Tacrolimus/pharmacology , Animals , Cells, Cultured , Escherichia coli , Macrophage Activation , Macrophages, Peritoneal/metabolism , Male , Nitrites/analysis , Rats , Rats, Wistar
12.
Biochem Pharmacol ; 58(3): 487-92, 1999 Aug 01.
Article in English | MEDLINE | ID: mdl-10424769

ABSTRACT

The diphosphoryl derivative of the acyclic nucleotide phosphonate analog 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA), found previously to weakly inhibit DNA pol delta/proliferating cell nuclear antigen, was studied as a substrate for pol alpha, delta, epsilon, and epsilon*. A comparison of the Vmax and Km for this derivative (PMEApp) and dATP demonstrated that the relative efficiency of the incorporation of this analog into the DNA chain is decreasing in the following order: pol delta approximately equal to pol epsilon approximately equal to pol epsilon* > pol alpha. Under the reaction conditions, this incorporation amounted to 4.4 to 0.7% of dAMP molecules. Similar Km values for PMEApp and dATP in pol epsilon and pol epsilon* catalyzed reactions revealed that proteolysis of the enzyme probably does not affect the dNTP binding site. The DNA polymerases tested were inhibited by the reaction product (PMEA terminated DNA chain) with similar Ki/Km ratios (pol alpha 0.2; pol delta, 0.1; pol epsilon 0.05; and pol epsilon*, 0.06). The associated 3'-5'-exonuclease activity of pol delta, epsilon, and epsilon* was able to excise PMEA from the 3'-OH end of DNA with a rate one order of magnitude lower than that of the dAMP residue.


Subject(s)
Adenine/analogs & derivatives , DNA Replication , DNA-Directed DNA Polymerase/metabolism , Organophosphonates , Adenine/chemistry , Adenine/metabolism , Adenine/pharmacology , Animals , DNA Polymerase I/metabolism , DNA Polymerase II/metabolism , DNA Polymerase III/metabolism , DNA Replication/drug effects , Rats , Rats, Sprague-Dawley , Substrate Specificity
15.
Anticancer Res ; 19(4B): 3173-82, 1999.
Article in English | MEDLINE | ID: mdl-10652608

ABSTRACT

Antitumor activity of the acyclic nucleotide analogs PMEDAP, PMEA, and PMEG was studied on a model of a spontaneous T-cell lymphoma in inbred SD/cub rats. Significant therapeutic effects were recorded after a treatment with 16 daily doses of PMEDAP at 5 mg/kg applied to the vicinity of the growing lymphoma. Identical administration of PMEA, or PMEG at a daily dose of 0.1 mg/kg did not affect the survival of lymphoma-bearing animals compared with untreated controls. A decrease in the lymphoma weight during PMEDAP administration was accompanied by the suppression of mitotic activity in neoplastic cells and increased chromatin condensation as witnessed by karyological examinations. Electron-microscopy showed the morphology of apoptotic cells (shrunken cells with condensed chromatin, apoptotic bodies) in lymphoma cell suspensions. An increase of nuclear DNA fragmentation was found during PMEDAP administration compared with spontaneous DNA fragmentation of untreated control lymphomas. These results indicate that PMEDAP application induces apoptosis in in vivo growing lymphomas. The antitumor effect of PMEDAP lasts only during the administration of the drug. After its cessation progression of neoplasia was reestablished.


Subject(s)
Adenine/analogs & derivatives , Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Lymphoma, T-Cell/pathology , Adenine/adverse effects , Adenine/pharmacology , Animals , Antineoplastic Agents/adverse effects , Cells, Cultured , Female , Lymphoma, T-Cell/ultrastructure , Microscopy, Electron , Neoplasm Transplantation , Rats , Rats, Sprague-Dawley , Tumor Cells, Cultured
16.
Folia Biol (Praha) ; 45(4): 121-31, 1999.
Article in English | MEDLINE | ID: mdl-10732725

ABSTRACT

Anticancer effect of heat shock, either alone or in combination with the drug PMEDAP, and cold water immersion stress were studied in an in vivo model of s.c. transplanted rat T-cell lymphomas in an inbred Sprague-Dawley rat line (SD/cub). Significant anticancer effect was induced by repeated sessions of heat shock; decrease of s.c. lymphoma weight and prolongation of survival time of treated rats was found to be dependent on the number of HS sessions. Much stronger therapeutic effect was observed after repeated heat shock in combination with PMEDAP administration. Light and electron microscopy studies were performed to characterize the alterations within the lymphomas. Morphologically, cellular alterations corresponding with apoptosis were observed in lymphoma cells after repeated heat shock. Indirect immunoperoxidase technique was used to detect HSP 72/73 protein(s), p53 and Bcl2 proteins in lymphomas heated directly or indirectly. The induction of HSP 72/73 protein(s) was found in the lymphoma tissues from autopsied animals exposed to heat shock; the intensity of its expression was dependent on the experimental design. The expression of p53 and BcL2 proteins was not changed in lymphoma cells of HS treated animals as compared to that of untreated lymphoma bearing controls; the Bcl2 protein was present in both treated and untreated lymphomas, and the p53 protein remained undetectable in all samples. Contrary to the heat shock, the cold stress did not suppress growth of lymphomas and, furthermore, accelerated the infiltration of parenchymatous organs with lymphoma cells.


Subject(s)
Hyperthermia, Induced , Lymphoma, T-Cell/therapy , Adenine/analogs & derivatives , Adenine/therapeutic use , Animals , Antimetabolites, Antineoplastic/therapeutic use , Apoptosis , Body Weight , Combined Modality Therapy , Cryotherapy , Female , HSP72 Heat-Shock Proteins , Heat-Shock Proteins/analysis , Immersion , Lymphoma, T-Cell/drug therapy , Lymphoma, T-Cell/genetics , Lymphoma, T-Cell/metabolism , Lymphoma, T-Cell/pathology , Male , Neoplasm Proteins/analysis , Neoplasm Transplantation , Neoplastic Syndromes, Hereditary/drug therapy , Neoplastic Syndromes, Hereditary/metabolism , Neoplastic Syndromes, Hereditary/pathology , Neoplastic Syndromes, Hereditary/therapy , Proto-Oncogene Proteins c-bcl-2/analysis , Rats , Rats, Sprague-Dawley , Stress, Physiological/pathology , Tumor Suppressor Protein p53/analysis
17.
Folia Biol (Praha) ; 44(4): 143-50, 1998.
Article in English | MEDLINE | ID: mdl-10732704

ABSTRACT

Changes in the karyotype in three spontaneous Sprague-Dawley rat lymphomas (SD7/95, SD8/96, SD9/96) have been studied in the course of in vivo passages. In individual lymphomas karyological findings of primary disease from lymph nodes were compared with changes found in the 1st and 10th passages of the lymphoma and bone marrow samples. Chromosome studies were performed on direct preparations using the G-banding technique. Chromosome counts of all specimens studied were near diploidy, the majority of metaphase cells being pseudodiploid. In later passages of two lymphomas, the tendency in selection to hyperdiploid karyotype, particularly in bone marrow was observed. The examination revealed an increased percentage of breaks in lymph node cells of primary disease and the existence of nonrandom change, derivative chromosome 11, which occurred in structural variability in all three lymphomas studied. The aberration involving chromosome 11 was evaluated as the addition of unknown material at chromosome band 11q11 or as a duplication or triplication of segment 11q12-q23. If this structural aberration was not found, the excessive derivative chromosome 11 or translocation t(11;13) was proved to be present. Further, rearrangements of chromosomes 13 and 7 were nonrandom chromosome abnormalities revealed in later passages of the lymphomas. The results are in accordance with our previous observations in 14 cases of SD lymphomas that showed nonrandom occurrence of rearrangements concerning chromosome 11 and also relatively frequent translocation involving chromosome 13.


Subject(s)
Chromosome Aberrations , Lymphoma/genetics , Animals , Bone Marrow Cells/ultrastructure , Chromosome Banding , Cytogenetics , Female , Karyotyping , Male , Neoplasm Transplantation , Rats , Rats, Sprague-Dawley , Time Factors , Transplantation, Isogeneic
18.
Proc Natl Acad Sci U S A ; 94(17): 9191-6, 1997 Aug 19.
Article in English | MEDLINE | ID: mdl-9256458

ABSTRACT

Although polyomavirus JC (JCV) is the proven pathogen of progressive multifocal leukoencephalopathy, the fatal demyelinating disease, this virus is ubiquitous as a usually harmless symbiote among human beings. JCV propagates in the adult kidney and excretes its progeny in urine, from which JCV DNA can readily be recovered. The main mode of transmission of JCV is from parents to children through long cohabitation. In this study, we collected a substantial number of urine samples from native inhabitants of 34 countries in Europe, Africa, and Asia. A 610-bp segment of JCV DNA was amplified from each urine sample, and its DNA sequence was determined. A worldwide phylogenetic tree subsequently constructed revealed the presence of nine subtypes including minor ones. Five subtypes (EU, Af2, B1, SC, and CY) occupied rather large territories that overlapped with each other at their boundaries. The entire Europe, northern Africa, and western Asia were the domain of EU, whereas the domain of Af2 included nearly all of Africa and southwestern Asia all the way to the northeastern edge of India. Partially overlapping domains in Asia were occupied by subtypes B1, SC, and CY. Of particular interest was the recovery of JCV subtypes in a pocket or pockets that were separated by great geographic distances from the main domains of those subtypes. Certain of these pockets can readily be explained by recent migrations of human populations carrying these subtypes. Overall, it appears that JCV genotyping promises to reveal previously unknown human migration routes: ancient as well as recent.


Subject(s)
Biological Evolution , Genetics, Population , JC Virus , Adult , Biomarkers , DNA, Viral/urine , Emigration and Immigration , Humans , Molecular Sequence Data
SELECTION OF CITATIONS
SEARCH DETAIL
...